TBC....................................................................
We want to solve immune dysfunction.
Many cancers and other diseases are caused, or resist treatment, because T cells can't recognize or
target cells correctly. We're progressing first-in-class antigen modulators through the clinic,
developed to treat disease by controlling T cell activation. Our technology modulates antigen
presentation, flicking a switch inside cells to alter their appearance to the immune system.
This approach marks a fundamental shift in how we treat people living with autoimmune disorders,
cancers and infectious diseases.
This is a unique opportunity to play a key role during one of the most important phases of the
company's development. You will shape the financial strategy of the organisation, support a planned
IPO, and help build the finance infrastructure required for long-term success as a listed
biotechnology company.
Open Post in Abingdon employer: Greywolf Therapeutics
At Greywolf, we are dedicated to pioneering solutions for immune dysfunction, making us an exceptional employer for those passionate about data and DevOps in the biotechnology sector. Our collaborative work culture fosters innovation and growth, offering employees the chance to shape our data strategy while enjoying flexible hybrid working arrangements and generous holiday benefits. Join us in our mission to advance groundbreaking discoveries and be part of a team that values your contributions and supports your professional development.
